The U.S. Justice Department convinced the District of Rhode Island to end a False Claims Act suit against pharmaceutical manufacturers and pharmacy benefit managers including
The DOJ demonstrated that whistleblower John R. Borzilleri’s suit accusing the companies of engaging in scheme to defraud Medicare Part D, a federal prescription drug program, would be too burdensome on government resources if allowed to continue, said Judge William E. Smith of the U.S. District Court for the District of Rhode Island.
The court said it had ...